Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Burden of adverse transplant outcomes in kidney transplant recipients with COVID-19 and invasive fungal infections: a retrospective cohort study.

BMC infectious diseases·2026
Same author

COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval.

Expert review of anti-infective therapy·2026
Same author

Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series.

The Journal of infectious diseases·2026
Same author

Clinical trial coordination of multifaceted ethical and regulatory oversight entities during the COVID-19 public health emergency.

Contemporary clinical trials·2025

相关实验视频

Updated: Jun 17, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.4K

康复性血用于免疫受损患者.

Shmuel Shoham1

  • 1Department of Medicine, Johns Hopkins School of Medicine, 1830 East Monument St., Room 447, Baltimore, MD, 21205, USA. sshoham1@jhmi.edu.

Current topics in microbiology and immunology
|August 8, 2024
PubMed
概括

COVID-19康复性血 (CCP) 为与COVID-19作斗争的免疫功能低下个体提供了至关重要的治疗方法. 证据支持其用于这些脆弱患者的急性和持续性感染.

科学领域:

  • 免疫学 免疫学 免疫学
  • 传染性疾病 传染性疾病
  • 血液学 血液学 血液学

背景情况:

  • 免疫功能低下的患者面临严重COVID-19并发症的风险增加.
  • 在这个人群中可能会发生持续性感染,需要有效的治疗策略.

研究的目的:

  • 审查使用COVID-19康复性血 (CCP) 在免疫受损患者中的理由和证据.
  • 评估CCP在治疗急性和持续性COVID-19感染中的有效性.

主要方法:

  • 文献综述包括案例系列,比较研究,随机试验和系统审查.
  • 对历史数据的分析和对抗体治疗的机制理解.
  • 包括来自多个实践指南的建议.

主要成果:

  • 来自各种研究类型的证据支持在免疫受损患者中使用CCP.
  • CCP在治疗急性和持续性COVID-19感染方面表现出价值.
  • 抗体作用机制和历史先例支持了治疗的合理性.

结论:

  • COVID-19康复性血对于免疫功能低下的患者来说是一个重要的治疗选择.
关键词:
在 COVID-19 疫情中,康复期间的血.免疫力受损的人.在白血病中,白血病.淋巴瘤是一种淋巴瘤.这就是SARS-CoV-2病毒.移植 移植 移植 移植

更多相关视频

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K
Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

4.0K

相关实验视频

Last Updated: Jun 17, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.4K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K
Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

4.0K
  • 该审查巩固了在这个患者群体中使用CPC的证据和指导方针.
  • 进一步的研究和准则的遵守对于最佳的患者结果至关重要.